Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload
Keyword(s):
Keyword(s):
2015 ◽
Vol 24
(3)
◽
pp. 293-300
◽
2010 ◽
Vol 1190
(1)
◽
pp. 151-158
◽